Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn's Disease Patients.

Rajat GargManik AggarwalRobert ButlerJean Paul AchkarBret LashnerJessica PhilpottBenjamin CohenTaha QaziFlorian RiederMiguel RegueiroBenjamin Click

Published in: Digestive diseases and sciences (2021)

UST is safe and effective in elderly CD. Although limited by sample size and retrospective design, such real-world data can inform biologic positioning in this IBD population.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
middle aged
rheumatoid arthritis
prognostic factors
community dwelling
patient reported outcomes
artificial intelligence